Myers, J. S., Sall, K. N., DuBiner, H., Slomowitz, N., McVicar, W., Rich, C. C., & Baumgartner, R. A. (2016). A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma. J Ocul Pharmacol Ther.
Chicago-stil citatMyers, Jonathan S., Kenneth N. Sall, Harvey DuBiner, Natanya Slomowitz, William McVicar, Cadmus C. Rich, och Rudolf A. Baumgartner. "A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma." J Ocul Pharmacol Ther 2016.
MLA-referensMyers, Jonathan S., et al. "A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma." J Ocul Pharmacol Ther 2016.